Cargando…

Phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis

PURPOSE: To evaluate the effectiveness of phacoemulsification for the prophylaxis of a glaucomatous crisis in the affected and contralateral eyes; to investigate the evolution of intraocular pressure levels after iridotomy and phacoemulsification; to assess the need for antiglaucoma medication after...

Descripción completa

Detalles Bibliográficos
Autores principales: Stock, Ricardo Alexandre, Röhrig, Mariéli Wobeto, Mezzomo, Camila Duranti, Bonamigo, Elcio Luiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733395/
https://www.ncbi.nlm.nih.gov/pubmed/31564822
http://dx.doi.org/10.2147/OPTH.S223496
_version_ 1783449977821855744
author Stock, Ricardo Alexandre
Röhrig, Mariéli Wobeto
Mezzomo, Camila Duranti
Bonamigo, Elcio Luiz
author_facet Stock, Ricardo Alexandre
Röhrig, Mariéli Wobeto
Mezzomo, Camila Duranti
Bonamigo, Elcio Luiz
author_sort Stock, Ricardo Alexandre
collection PubMed
description PURPOSE: To evaluate the effectiveness of phacoemulsification for the prophylaxis of a glaucomatous crisis in the affected and contralateral eyes; to investigate the evolution of intraocular pressure levels after iridotomy and phacoemulsification; to assess the need for antiglaucoma medication after the proposed treatments; and to identify potential complications associated with phacoemulsification. PATIENTS AND METHODS: This retrospective observational study evaluated 22 eyes of 12 patients between September 2006 and September 2018, with a minimum follow-up period of 9 months. RESULTS: After iridotomy, a persistent increase in intraocular pressure was observed in 42.85% of the cases, 100% of the patients required antiglaucoma medications, and recurrence of angle closure was observed in 28.57% of the cases. In contrast, during follow-up of phacoemulsification, the intraocular pressure levels in all eyes evaluated remained normal, without the need for medication, and no recurrence of the glaucomatous crisis or other complications was observed. CONCLUSION: Phacoemulsification maybe consequently more effective than laser iridotomy for the resolution of angle-closure glaucoma and particularly for preventing its relapses.
format Online
Article
Text
id pubmed-6733395
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-67333952019-09-27 Phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis Stock, Ricardo Alexandre Röhrig, Mariéli Wobeto Mezzomo, Camila Duranti Bonamigo, Elcio Luiz Clin Ophthalmol Original Research PURPOSE: To evaluate the effectiveness of phacoemulsification for the prophylaxis of a glaucomatous crisis in the affected and contralateral eyes; to investigate the evolution of intraocular pressure levels after iridotomy and phacoemulsification; to assess the need for antiglaucoma medication after the proposed treatments; and to identify potential complications associated with phacoemulsification. PATIENTS AND METHODS: This retrospective observational study evaluated 22 eyes of 12 patients between September 2006 and September 2018, with a minimum follow-up period of 9 months. RESULTS: After iridotomy, a persistent increase in intraocular pressure was observed in 42.85% of the cases, 100% of the patients required antiglaucoma medications, and recurrence of angle closure was observed in 28.57% of the cases. In contrast, during follow-up of phacoemulsification, the intraocular pressure levels in all eyes evaluated remained normal, without the need for medication, and no recurrence of the glaucomatous crisis or other complications was observed. CONCLUSION: Phacoemulsification maybe consequently more effective than laser iridotomy for the resolution of angle-closure glaucoma and particularly for preventing its relapses. Dove 2019-09-05 /pmc/articles/PMC6733395/ /pubmed/31564822 http://dx.doi.org/10.2147/OPTH.S223496 Text en © 2019 Stock et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Stock, Ricardo Alexandre
Röhrig, Mariéli Wobeto
Mezzomo, Camila Duranti
Bonamigo, Elcio Luiz
Phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis
title Phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis
title_full Phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis
title_fullStr Phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis
title_full_unstemmed Phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis
title_short Phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis
title_sort phacoemulsification: an alternative for prophylaxis of a glaucomatous crisis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733395/
https://www.ncbi.nlm.nih.gov/pubmed/31564822
http://dx.doi.org/10.2147/OPTH.S223496
work_keys_str_mv AT stockricardoalexandre phacoemulsificationanalternativeforprophylaxisofaglaucomatouscrisis
AT rohrigmarieliwobeto phacoemulsificationanalternativeforprophylaxisofaglaucomatouscrisis
AT mezzomocamiladuranti phacoemulsificationanalternativeforprophylaxisofaglaucomatouscrisis
AT bonamigoelcioluiz phacoemulsificationanalternativeforprophylaxisofaglaucomatouscrisis